qlsyy.net - Rasio total nilai perusahaan marang pendapatan QLI

Simbol resmi perusahaan qlsyy.net (QLI)

Chinese generic drug and organic compound manufacturer Qilian International (QLI) is modernizing its raw material synthesis, while the enterprise value-to-revenue multiple reflects a trend where the indicator reaches . High barriers to entry are maintained through government licensing and component quality. The stability of the technical staff is further enhanced by the strategic hiring of external sales experts.

QLI Rasio nilai perusahaan marang pendapatan qlsyy.net (04.07.2022 - 20.11.2026)

Qilian International Corp - rincian analitis lan metrik utama (QLI)

- rega saham lan prakiraan rega para ahli:
Analisis wiwitan perusahaan:Qilian International Holding, QLI
Sampel barang Qilian International Holding Group Limited

To objectively assess the operational efficiency of Qilian International (QLI), it is essential for investors to understand the real value of the business without the distortions introduced by debt load. By analyzing the enterprise value-to-sales multiple, you compare the total asset value with the revenue generated from the innovative extraction of bioactive substances, which helps determine whether the market price of the shares is fair relative to the issuer's technological potential within the chemical industry.

Pesaing langsung

HLN: Rasio nilai perusahaan marang pendapatan|Kenvue Corp (KVUE) - Rasio nilai perusahaan marang pendapatan|Verona Pharma PLC - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Jyong Biotech Ltd|Multiplikator EV/Sales Ligand Corp|Multiplikator EV/Sales AMRX|Rasio total nilai perusahaan marang pendapatan Perrigo Company plc|Multiplikator EV/Sales ALVO (Alvotech Biopharmaceuticals)|LQDA: Rasio nilai perusahaan marang pendapatan|Galapagos N.V. - Multiplikator EV/Sales|ANIP - Multiplikator EV/Sales|MNKD: Multiplikator EV/Sales|amphastar.com (AMPH) - Multiplikator EV/Sales|PCRX (Pacira Pharmaceuticals) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan ARS Pharmaceuticals, Inc. (SPRY)|Multiplikator EV/Sales TBPH|AQST (Aquestive Therapeutics) - Nilai bisnis marang pendapatan|scPharmaceuticals, Inc. - Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan TECX|tonixpharma.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan BioHarvest|Nilai perusahaan marang pendapatan EXOZ|Nilai perusahaan marang pendapatan Oramed Pharmaceuticals (ORMP)|Nilai perusahaan marang pendapatan ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABVC (ABVC BioPharma Inc)|CPIX - Nilai perusahaan marang pendapatan|Quantum BioPharma Corp - Multiplikator EV/Sales|FGEN (fibrogen.com) - Rasio nilai perusahaan marang pendapatan|TELO (Telomir Pharmaceuticals) - Nilai perusahaan marang pendapatan|Rani Therapeutics Holdings - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan SNYR|Multiplikator nilai perusahaan marang pendapatan rallybio.com RLYB|Multiplikator EV/Sales LEXX|PULM (Pulmatrix, Inc.) - Nilai bisnis marang pendapatan|Pheton Holdings - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales Aptorum Group Limited APM|LYRA: Nilai perusahaan marang pendapatan|IBO: Rasio nilai perusahaan marang pendapatan|TNFA: Multiplikator EV/Sales|YCBD: Koefisien nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan PainReform Ltd|CYTO (altamiratherapeutics.com) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIPO|OPTN - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan pieris.com PIRS|Nilai bisnis marang pendapatan PROC|PTPI - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan SLRN (ACELYRIN)|TFF Pharmaceuticals, Inc (TFFP) - Rasio nilai perusahaan marang pendapatan